Beneath Noise Of Indian Drug Regulatory Reforms Is Weak ADR Reporting Infrastructure
This article was originally published in PharmAsia News
Executive Summary
The Indian government is pushing hard for drug regulatory reforms at multiple levels, from a central drug authority to increasing trained staff. But data show that Adverse Drug Reaction reporting standards are still in their infancy and sorely lacking.